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ADP-Ribosylation Factor-Like 2 
(ARL2) regulates cilia stability and 
development of outer segments in 
rod photoreceptor neurons
Zachary C. Wright1, Yuriy Loskutov2, Daniel Murphy2, Peter Stoilov2, Elena Pugacheva2, 
Andrew F. X. Goldberg  4 & Visvanathan Ramamurthy1,2,3
Photoreceptor cells are specialized neurons with a sensory cilium carrying an elaborate membrane 
structure, the outer segment (OS). Inherited mutations in genes involved in ciliogenesis frequently 
result in OS malformation and blindness. ADP-ribosylation factor-like 2 (ARL2) has recently been 
implicated in OS formation through its association with Binder of ARL2 (BART or ARL2BP), a protein 
linked to inherited blinding disease. To test the role of ARL2 in vision we created a transgenic mouse 
model expressing a tagged-dominant active form of human ARL2 (ARL2-Q70L) under a rod-specific 
promoter. Transgenic ARL2-Q70L animals exhibit reduced photoreceptor cell function as early as 
post-natal day 16 and progressive rod degeneration. We attribute loss of photoreceptor function to 
the defective OS morphogenesis in the ARL2-Q70L transgenic model. ARL2-Q70L expression results 
in shortened inner and outer segments, shortened and mislocalized axonemes and cytoplasmic 
accumulation of rhodopsin. In conclusion, we show that ARL2-Q70L is crucial for photoreceptor neuron 
sensory cilium development. Future research will expand upon our hypothesis that ARL2-Q70L mutant 
interferes with microtubule maintenance and tubulin regulation resulting in impaired growth of the 
axoneme and elaboration of the photoreceptor outer segment.
The outer segment (OS) of photoreceptor neurons is a non-motile cilium that is specialized in light perception1. 
Defective OS formation affects vision and is often a consequence of impaired ciliogenesis in ciliopathic diseases2,3.
To gain insight into the development of the OS and related diseases, it is crucial to identify the proteins and 
events involved in this process. A number of small GTPases, which act as molecular switches, are believed to play 
a role in regulating protein-protein interactions throughout the process of ciliogenesis and OS formation1,4–6. 
These proteins are likely involved in the temporal and spatial regulation of ciliary proteins and add a level of com-
plexity to photoreceptor morphogenesis. Specifically, the ADP-ribosylation factor-like 2 (ARL2) small GTPase 
was implicated in the process of OS formation in photoreceptor cells through its interaction of the Retinitis 
Pigmentosa (RP)-linked gene, ARL2 Binding Protein (ARL2BP)7. Importantly, ARL2 selectively interacts with 
ARL2BP in the GTP-bound active state8.
Despite the connection to OS formation through ARL2BP, there is little direct evidence for the role of ARL2 in 
photoreceptor neurons as well as in vivo function of this protein in general. Studies of ARL2 and ARL3, a close ARL2 
homolog, suggest that they may have overlapping functions. Specifically, they are thought to regulate trafficking of 
prenylated proteins through their interaction with prenyl binding protein δ (PrBPδ)9,10. This function of ARL3 has 
been shown in vivo by multiple animal models, including dominant active transgenic ARL3-Q71L and conditional 
ARL3 knockout mice11,12. However, a role for ARL2 in prenylated protein trafficking has yet to be tested in vivo.
ARL2 has been implicated in a number of cellular processes9,13–17. ARL2 is thought to play a role in microtu-
bule formation and regulation of the soluble tubulin pool14,16,18–20. A number of studies have shown that expres-
sion of dominant active ARL2 causes microtubule destruction by preventing polymerization14,16,20. More recent 
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studies propose that active ARL2-GTP may interact with tubulin binding cofactors D and E (i.e. TBCD and 
TBCE) to regulate the state of tubulin dimerization and therefore the pool of free polymerizable tubulin19. In 
agreement with the proposed role in microtubule formation, knockdown of ARL2 or its binding partner ARL2BP 
results in shortening of cilia in ARPE-19 cell lines7. In addition, ARL2 is localized at the centrosome in cell lines 
where it is proposed to act as a microtubule regulator in an ARL2BP-independent manner14. These data suggest 
that ARL2 may play a role in OS formation by regulating tubulin or ARL2BP at photoreceptor cilium.
The purpose of this study was to gain insight into the role of ARL2 in rod photoreceptor cells by expression 
of the dominant active mutant ARL2-Q70L. Here we show for the first time that proper regulation of ARL2 is 
necessary for rod cilia regulation and OS formation.
Results
Endogenous Arl2 Expression Profile and Dominant Active Mutant Transgenic Model Generation. 
To understand the role of ARL2 in mouse photoreceptor cells, it is important to know the temporal dynamics of 
Arl2 gene expression. We examined the developmental retinal mRNA expression profile of endogenous Arl2 and 
Arl3 in mice (Fig. 1A). We quantified by real time RT-PCR the message levels of Arl2 and Arl3 from post-natal 
day 0 (P0) through P16. As shown in the figure, Arl2 expression remains low until a 4-fold spike in message levels 
between ages P6 and P9. This “switch” in expression suggests a functional need for ARL2 corresponding to elab-
oration of the OS, which begins at postnatal day 8. Arl3 expression was also elevated between P6 and P9, but the 
change was moderate in comparison to Arl2.
To determine the role of ARL2 in photoreceptor function, we generated a transgenic animal expressing domi-
nant active human ARL2-Q70L in rod photoreceptor cells (Fig. 1B). Expression of ARL2-Q70L in the transgene is 
under the control of a rhodopsin promoter (Rhop) that initiates the expression of transgenes as early as post-natal 
day 4 (P4) in rod photoreceptor cells of the retina21. This approach is similar to our recently published work where 
we expressed ARL3 in rod photoreceptor cells11. Transgenic founders were crossed with 129/SV-E wild-type mice 
for a few generations to ensure consistent transgene inheritance and expression prior to analysis. Over 8 trans-
genic founder lines were assessed for homogeneity of transgene expression and the lines utilized herein displayed 
the most homogeneous expression in photoreceptor cells. Transgenic negative littermates of ARL2-Q70L mice 
were used as control animals for comparison unless stated otherwise.
Figure 1. Expression of Arl2 and Creation of Dominant Active Mutant Transgenic Model. This figure illustrates 
the developmental mRNA expression of Arl2 and Arl3 in mouse retina as well as the expression of dominant active 
ARL2 in our transgenic animal model. (A) Arl2 and Arl3 mRNA expression was determined by quantitative PCR 
of mouse retinal tissues from P0 to P16. Expression levels are displayed as fold change relative to the expression 
observed at P0 (n = 5). (B) This scheme illustrates the construct used for transgenic mouse generation. Human 
Arl2 Q70L (ARL2 Q70L; glutamine to leucine dominant active mutant) expression is driven by a 4.4 Kb rhodopsin 
promoter (Rhop). The ARL2 Q70L protein is also tagged at the C-terminus with hemagglutinin (HA) and FLAG 
epitope. (C) Western blot analysis of endogenous versus transgenic ARL2 protein levels in P13 retinal tissue 
samples by staining with ARL2 (red) and HA (green) directed antibodies. Refer to bar graph for quantitation of 
total ARL2 (endogenous + transgenic ARL2-Q70L) expression levels relative to total ARL2 protein expression in 
controls using the ARL2 directed antibody (red) (n = 4; p = 0.012; * = p < 0.05). (D) Immunofluorescence analysis 
of retinal Tg(−) and Tg(+) cross sections from P13 animals. The localization of transgenic ARL2 was identified 
by incubating with HA directed antibody (red) and the OS were identified by staining with peripherin-2 (green) 
(Scale Bar = 20 μm). (E) Localization of endogenous ARL2 (using ARL2-directed antibody – red) and the ciliary 
marker acetylated tubulin (green) in P13 Tg(−) cross sections (Scale bar = 10 μm).
www.nature.com/scientificreports/
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We generated an affinity purified rabbit antibody against ARL2. This antibody specifically recognized ARL2 
and not its homologue ARL3 expressed in Human Embryonic Kidney (HEK293) cells (data not shown). In ret-
ina from transgenic animals at P13 using an ARL2-directed antibody (red), we find that ARL2-Q70L (~23 kDa) 
was expressed at 40% the level of endogenous ARL2 (~20 kDa) protein (Fig. 1C; n = 4; p < 0.001) while the total 
ARL2 (endogenous ARL2 + transgenic ARL2-Q70L) was ~14% greater than the total ARL2 protein in controls 
(Fig. 1C; n = 4; p = 0.012). Additionally, an anti-HA antibody (green) was used to confirm the identity of the 
tagged ARL2-Q70L, which overlaps with the ARL2 directed antibody fluorescence (red) at ~23 kDa (Fig. 1C).
The expression of transgenic ARL2-Q70L at P13 was confirmed by indirect immunofluorescence with 
anti-HA antibody (Fig. 1D). ARL2-Q70L was found in photoreceptor cells. Unlike transgenic and endogenous 
ARL3 localization examined in our previous study11, we observed intense transgenic protein fluorescence in the 
photoreceptor cell inner segment, ONL, and outer plexiform layer and only minimal overlap with the OS marker 
peripherin in the OS (Fig. 1D,E). Endogenous ARL2 fluorescence was observed throughout the IS and the OS 
with greater intensity in the IS-OS boundary (Fig. 1D,E).
Overall, these data demonstrate a switch in endogenous Arl2 expression between P6 and P9, coinciding with 
the early stages of photoreceptor OS elaboration22, and that transgenic ARL2 is localized throughout photore-
ceptor cells with greatest abundance in the IS, ONL, and outer plexiform layer.
Decreased photoreceptor function in ARL2-Q70L mice. We performed electroretinography (ERG) 
starting from P16 to determine the impact of expression of dominant active ARL2 on photoreceptor cell func-
tion. Transgenic ARL2-Q70L animals exhibited a major ~70% reduction in scotopic a-wave at P16 compared 
to transgenic littermate controls which showed a robust a-wave and b-wave (Fig. 2A; Tg(−) = 379.8 ± 7.2 μV 
and Tg(+) = 120.0 ± 3.3 μV, n = 5, p < 0.0001). As expected, cone photoreceptor response remained unaffected 
at this time point as transgenic negative and transgenic positive photopic b-waves were comparable (Fig. 2A; 
Tg(−) = 123.18 ± 6.4 μV and Tg(+) = 138.2 ± 1.9 μV; n = 5, p = 0.17). Rod photoresponse progressively declined 
in transgenic ARL2-Q70L animals with an 85% reduction in a-wave by P100 compared to littermate controls 
(Fig. 2A,B; Tg(−) = 379.3 ± 19.6 μV and Tg(+) = 60.7 ± 9.7 μV, n = 5, p < 0.0001). Finally, only a slight difference 
in rod sensitivity was noted with scotopic a-wave half-saturating light intensities of 0.010 ± 0.0019 cd*s/m2 in 
Tg(+) animals versus 0.014 ± 0.0018 cd*s/m2 in littermate controls and calculated maximum a-wave amplitudes 
of 225.2 ± 6.6 μV (Tg(+))and 499.7 ± 10.6 μV (Tg(−)). Taken together, these results illustrate that expression of 
ARL2-Q70L reduced rod photoreceptor function.
Rod photoreceptor cells degenerate in animals expressing ARL2-Q70L. We observed a gradual 
decline in photoreceptor function as the animals aged (Fig. 2B). To determine if the reduction in photoreceptor 
function is due to photoreceptor cell death, we examined the outer nuclear layer (ONL) length from P13 to P110. 
At P13, there was no difference in the size of the ONL (Fig. 3A,B; Tg(−) = 11.0 layers versus Tg(+) = 10.2 lay-
ers; n = 4, p = 0.26), however, there was a noticeable increase in the number of apoptotic nuclei observed with 
propidium iodide. At P16 apoptotic nuclei were more frequent with a minor decrease in the ONL length. (Fig. 3A, 
arrows indicate apoptotic nuclei). By P60 there was a major loss of photoreceptor cells and by P110 the ONL was 
nearly gone with only 1–3 nuclear layers remaining (Fig. 3A,B; P110: Tg(−) = 10.2 layers and Tg(+) = 2.0 layers; 
n = 4, p < 0.01 at all locations). These data suggest that defects during the development of rod photoreceptor cells 
results in progressive degeneration.
Figure 2. Reduced photoreceptor response in ARL2-Q70L mice. (A) Representative scotopic (rod) and 
photopic (cone) electroretinograms (ERGs) comparing Tg(−) and Tg(+) animals at P16 and P100 across 
multiple light intensities. (B) Graph showing the scotopic a-wave amplitude measured at the light intensity of 
−0.8 log (cd*s/m2) at different ages. n = 5; *p < 0.01.
www.nature.com/scientificreports/
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Reduction of photoreceptor OS proteins ARL2-Q70L animals. The reduction in photoresponse of 
ARL2-Q70L animals at P16 does not correlate to the minor loss of cells at that age. This suggests a defect in the 
phototransduction cascade or a reduction in levels of phototransduction proteins. Previous in vitro studies have 
implicated ARL2 as a regulatory protein for prenylated cargo through its interaction with PrBPδ, similar to its 
homolog ARL39,10. Therefore, we investigated the levels of prenylated phototransduction proteins along with 
other non-prenylated proteins in ARL2-Q70L expressing animals prior to degeneration (Fig. 4). The prenylated 
proteins phosphodiesterase 6 α (PDE6α) and β (PDE6β) subunits were significantly reduced by ~30% at P13 
compared to transgenic negative littermates (PDE6α: P13 ≈ −30% p < 0.001; PDE6β: P13 ≈ −34% p < 0.01; 
n = 4). Similarly, farnesylated G-protein coupled receptor kinase 1 (GRK1), rod transducin γ subunit (Gγ1), and 
myristoylated rod transducin α (Gαt1) were all significantly reduced at P13 (GRK1: P13 ≈ −17% p < 0.01; Gγ1: 
P13 ≈ −50% p < 0.01; Gαt1: P13 ≈ −11% p < 0.01; n = 4). However, to our surprise, the non-prenylated OS 
proteins guanylate cyclase 1 (GC1), rhodopsin, and peripherin-2/rds were also significantly reduced by approx-
imately the same magnitude as the prenylated proteins (GC1: P13 ≈ −31% p < 0.05; rhodopsin: P13 ≈ −51% 
p < 0.001; peripherin-2/rds: P13 ≈ −30% p < 0.05; n = . 4). A similar pattern was seen in P16 retinal samples 
as well. These proteins were all normalized to Goα, which is expressed in the bipolar cells and was unchanged 
between transgenic and littermate controls (P13: p = 0.33; n = 4). Additionally, tubulin was unchanged between 
transgenic animals and controls (P13: p = 0.99; n = 4). These results are in contrast to mouse models disrupting 
the ARL2 homolog, ARL3, which result in specific loss of prenylated proteins prior to cell death11,12. The broad 
decrease in photoreceptor OS proteins suggests that ARL2 is not acting specifically through PrBPδ to disrupt 
prenylated proteins.
Figure 3. Degeneration of Rod photoreceptor cells in animals expressing ARL2-Q70L. (A) Retinal sections 
of Tg(−) and Tg(+) littermates stained with propidium iodide to demonstrate the ONL integrity at different 
ages (P13, P60, and P110). (B) Quantification of the ONL length (number of nuclei) between Tg(−) and Tg(+) 
littermates at different locations within the retina from the inferior (−3) to superior (3) portion at P13 and 
P110. n = 4; *p < 0.01 (Scale Bar = 20 μm).
Figure 4. Reduced levels of photoreceptor OS proteins in ARL2-Q70L animals. Representative immunoblots 
showing expression of proteins from retinal lysates of Tg(−) and Tg(+) littermates at P13. Quantification 
of these protein levels is shown in the bar graph on the right. All samples were normalized to Goα, a protein 
expressed in the bipolar cells. n = 4, *p < 0.05.
www.nature.com/scientificreports/
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Mislocalization of Rhodopsin in ARL2-Q70L animals. The ARL2 homolog, ARL3, regulates trafficking 
of prenylated proteins to the rod OS11,12. Transgenic animals expressing ARL3-Q70L showed disrupted traffick-
ing of prenylated PDE6 and normal distribution of rhodopsin11. Therefore, we wanted to determine if ARL2 
serves a redundant function to ARL3 in this process. To answer these questions, we examined localization of 
rod OS-resident proteins using immunofluorescence microscopy at P13 (Fig. 5). Rhodopsin was dramatically 
mislocalized to the ONL surrounding the nuclei as well as the IS and synapse at P13 in ARL2-Q70L animals 
(Fig. 5, Panel B). Immunoreactivity for PDE6 was also intermittently found in the IS and ONL, but to a much 
lesser extent (Fig. 5, Panel A). The localization of rod transducin and GRK1 appears normal (Fig. 5, Panel C and 
D) This is contrary to the mislocalization seen in our previous work with the ARL3-Q70L model in which preny-
lated proteins GRK1, PDE6, and rod transducin were mislocalized to vacuole-like structures in the rod IS11. This 
observation adds support for a role of ARL2 in photoreceptor development and function that is different from its 
close paralogue ARL3.
Abnormal elaboration of photoreceptor OS in ARL2-Q70L Mice. The broad decrease in OS protein 
levels in the ARL2-Q70L transgenic line with no major loss in photoreceptor cells at P13, can be explained by 
a structural defect of the OS. For initial insight into photoreceptor cell structure, we examined the morphology 
of the toluidine blue stained retinal sections by light microscopy. We examined retinal sections from animals at 
P13 and P16, before ONL degeneration and after initial significant photoreceptor loss, respectively. Transgenic 
ARL2-Q70L had a significant ~2-fold decrease in the OS length at P13 (Fig. 6; P13: Tg(−) = 10.9 ± 1.1 μm 
versus Tg(+) = 4.9 ± 0.5, n = 4, p < 0.05). Furthermore, there was a significant ~1.7-fold decrease in IS length 
Figure 5. Defective localization of Rhodopsin in ARL2-Q70L animals. Immunofluorescence analysis of 
OS proteins in Tg(−) and Tg(+) samples at P13. PDE6β (A), Rhodopsin (B), GαT1 (C), and GRK1 (D) 
with unadjusted image intensity (Top) and enhanced image intensity to visualize immunoreactivity of lower 
abundance proteins in the ONL (Bottom). (Scale Bar = 20 μm).
www.nature.com/scientificreports/
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in Tg(+) at P13 (Fig. 6; P13: Tg(−) = 12.7 ± 0.1 μm versus Tg(+) = 7.4 ± 0.2 μm, n = 4, p < 0.001). However, 
there were no significant differences in ONL length between transgenic negative and positive at P13 (Fig. 6; P13: 
Tg(−) = 53.2 ± 2.7 μm versus Tg(+) = 52.3 ± 1.6 μm, n = 4, p = 0.79). Similar results were found at P16 except 
there was a minor, but significant reduction in the ONL length at this age. These data further support the con-
clusion that transgenic expression of ARL2-Q70L impedes the development of the photoreceptor outer segment.
ARL2-Q70L expression results in defects in cilia regulation and OS development in rod pho-
toreceptor cells. ARL2 has recently been implicated in the regulation of ciliary length in vitro7. To explore 
this potential role in intact photoreceptor cells, immunofluorescence and transmission electron microscopy were 
performed to examine axonemal integrity and rod photoreceptor cell ultrastructure. RP1 and RPGR immuno-
reactivity were used to determine the length of the connecting cilium and axoneme in the ARL2-Q70L retina at 
P14 (Fig. 7A). Immunoreactivity of these two markers in control Tg(−) retina produced uniform staining at the 
IS-OS border with 1 to 2 μm connecting cilium extending to a 2–4 μm axoneme (Fig. 7A; Top Panel). However, 
in transgenic animals (Tg(+)) the IS-OS border is less apparent with a number of instances of cilium staining 
within the IS region near the outer limiting membrane (OLM) (Fig. 7A; Bottom Panel; White Arrows). Although 
the length of the connecting cilium, as measured by RPGR immunoreactivity is comparable to wild type tissue, 
the length of the axoneme (measured by RP1 immunoreactivity) is dramatically shorter (Fig. 7A; Bottom Panel). 
More specifically, ciliary length in Tg(+) animals was on average ~2-fold shorter than littermate controls with 
approximately 70% of cilia between 1 and 2 μm compared to the same proportion between 3 and 4 μm (Fig. 7A; 
Right). This reduction in axoneme length was also confirmed using anti-MAK antibodies which are used as a 
marker for the connecting cilium and axoneme (Fig. 7A; Bottom-Left).
To explore possible ultrastructural defects, electron microscopy was performed at P13 prior to the onset of 
photoreceptor cell death. Photoreceptor OSs were frequently shorter and misoriented in comparison to wildtype 
controls (Fig. 7B,C; White Arrowheads). Additionally, aberrantly localized cilia were found protruding from the 
lower portions of the IS near the OLM (Black Arrows) in the retina from transgenic positive animals while other 
cilia were localized normally at the apical IS. In contrast, there is a clear demarcation between the inner and outer 
segment in the transgenic negative littermates with all cilia properly localized at the apical IS (Fig. 7B,C). Similar 
to our findings from light microscopy, the IS was dramatically shorter. Overall, these results suggest that expres-
sion of ARL2-Q70L interferes with the development of the ciliary axoneme and the photoreceptor OS.
ARL2-Q70L expression negatively affects ciliary stability in RPE1-hTERT cell lines. To deter-
mine if the decrease in axoneme length is specific to photoreceptor cells we generated stable RPE1-hTERT cell 
lines with a dox-inducible promoter driving expression of ARL2-WT or ARL2-Q70L. As described previously23, 
ciliation was induced by switching to serum free media. Doxycycline was added after 24 hr of serum starvation 
to the medium to induce expression of ARL2 protein from the lentiviral vector. Induction of transgene expres-
sion 24 hr after serum starvation was completed to isolate the effects of the transgenic protein on cilia stability 
based on previous work demonstrating that the number of cilia remain unchanged from 24 hr to 48 hr of serum 
starvation23. Immunoreactivity to γ-tubulin and acetylated α-tubulin was used to locate and measure the length 
of cilia in these cells. We observed 20% reduction in the fraction of ciliated cells with a 30% decrease in the 
length of cilia in ARL2-Q70L expressing cells compared to un-induced (Dox(−)) controls or to cells expressing 
wild type ARL2 protein (Fig. 8A,B). Additionally, expression of wild type ARL3 or dominant active ARL3-Q71L 
did not affect cilia length of the rate of ciliation (Cilia length: ARL3-WT – Dox(−) 2.49 ± 0.02 μm vs. Dox(+) 
2.42 ± 0.05 μm, p = 0.36; ARL3-Q71L – Dox(−) 2.43 ± 0.02 μm vs. Dox(+) 2.65 ± 0.10 μm, p = 0.17; Fraction of 
ciliated cells/total cells: ARL3-WT – Dox(−) 0.59 ± 0.02 vs. Dox(+) 0.57 ± 0.06, p = 0.75; ARL3-Q71L – Dox(−) 
0.65 ± 0.07 vs. Dox(+) 0.53 ± 0.03, p = 0.25; n = 3 for all endpoints). These data confirm the results obtained in 
the ARL2-Q70L transgenic model and further support the role for ARL2 in ciliary stability and maintenance of 
axoneme length.
Figure 6. Aberrant elaboration of photoreceptor OS in ARL2-Q70L Mice. Representative toluidine blue stained 
retinal cross sections from Tg(−) and Tg(+) littermates at P13 and P16. Quantification of the OS, IS and ONL 
length from these animals at respective ages. n = 4, *p < 0.05. (scale bar = 20 μm).
www.nature.com/scientificreports/
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Discussion
In this study, we have discovered a novel regulator of rod photoreceptor development and function, ARL2. Our 
first indication that ARL2 plays a role in OS morphogenesis was the endogenous mRNA expression profile, which 
demonstrates a “switch”-like spike in retinal message levels at approximately P9, a critical period of OS elab-
oration (Fig. 1A). Furthermore, we observed localization of endogenous ARL2 in the area of the connecting 
cilium via immunofluorescence microscopy. In order to study ARL2 in rod photoreceptor neurons, we generated 
a dominant active transgenic mouse model that expresses ARL2-Q70L mutant under a rod promoter (Rhop). 
The expression of the transgenic protein was 40% the level of endogenous ARL2 and the total amount of ARL2 
(transgenic + endogenous) in transgenic animals only 14% greater than the total ARL2 protein in transgenic 
negative animals. This result suggests a strong mechanism of regulation of ARL2 protein levels and the downreg-
ulation of native protein in our model to compensate for the expression of transgenic ARL2-Q70L. Interestingly, 
this finding is unique to expression of ARL2-Q70L as it was not present in our previous work with transgenic 
expression of ARL3-Q71L, which showed as much as 300% more transgenic ARL3-Q71L compared to controls11. 
This strengthens the idea that the phenotypes presented here do not result solely from effects of overexpression 
of exogenous protein. With this model, we demonstrate that expression of ARL2-Q70L results in early defects in 
OS development followed by slow photoreceptor degeneration. Additional support for the role for ARL2 in OS 
morphogenesis comes from recently described animal model lacking ARL2 in the retina24.
Figure 7. Defective development of photoreceptor axoneme and OS in rods expressing ARL2-Q70L. (A) 
Immunofluorescence analysis of retinal cross sections of Tg(−) and Tg(+) littermates at P14 showing 
immunoreactivity for DAPI (blue), acetyl α-tubulin (red), RPGR or MAK (green), and RP1 (magenta) (Scale 
Bar = 10 μm). A frequency distribution illustrating the fraction of total measured cilia (length from base of 
RPGR to tip of RP1 immunoreactivity) ranging between 0-1, 1-2, 2-3, 3-4, 4-5, and 5 + microns (White arrows 
indicate mislocalized cilia). n = 3. (B) Electron micrographs of retinal cross sections at low magnification of 
Tg(−) and Tg(+) littermates at P13 illustrating the structural abnormalities including misoriented, dysmorphic 
and shortened OS discs (white arrowheads), shorter IS length, and aberrantly localized cilia near the OLM 
(black arrows) in Tg(+) (Scale Bar = 2 μm). (C) High magnification electron micrographs highlighting 
ultrastructural defects. Black arrows indicate misoriented or mislocalized basal bodies and cilia. White 
arrowheads indicate misoriented/dysmorphic OS discs (Scale Bar = 0.5 μm).
www.nature.com/scientificreports/
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The phenotype observed in ARL2-Q70L model is distinct from that of the ARL3-Q71L lines generated for pre-
vious work11. Specifically, ARL3-Q71L transgenic animals exhibit normal photoreceptor elaboration and function 
at P20 with a rapid decline in function between the ages of P30 and P70 and concomitant degeneration of rods 
by P70. ARL2-Q70L transgenic animals have a decrease in the length of the photoreceptor OS and IS as early as 
P13 and abnormal rod function at P16 with a slow decline and degeneration up to P100. Interestingly, the local-
ization of ARL2 and ARL3 are different in photoreceptor cells. While native ARL2 and ARL2-Q70L is confined 
to the IS, native ARL3 and ARL3-Q71L is present in both IS and OS11. Previous studies suggest that ARL2 may 
act similarly to ARL3 as a selective regulator for prenylated protein trafficking9–11. However, we observed minor 
mislocalization of the majority of prenylated proteins to the OS, which we attribute to a stunted OS. This is in con-
trast to ARL3-Q71L transgenic animals, which show progressive mislocalization of PDE6 and other prenylated 
proteins with no effect on OS elaboration. Immunoblotting from ARL2-Q70L retina shows a uniform decrease in 
the levels of OS proteins and not a selective decrease in prenylated proteins as occurs in ARL3-Q71L transgenic 
retina. Although we cannot completely rule out that ARL2 may act in prenylated protein trafficking, we can say 
that it does not appear to be its primary role in vivo. Unlike ARL2-Q70L, neither ARL3 wildtype or dominant 
active ARL3-Q71L expression in RPE1-hTERT cells resulted in abnormalities in ciliation or axonemal length. 
These data demonstrate a novel role for ARL2 in rod photoreceptor cells that is distinct from its homolog ARL3.
We believe the mislocalization of rhodopsin in ARL2-Q70L animals is a consequence of the morphological 
defects in the OS elaboration, similar to other cases where shortening of the OS or loss of the connecting cilium 
results in mislocalization of rhodopsin12,25. However, it is important to note that knockout and heterozygote mice 
for rhodopsin result in the absence of or shorter OS, respectively26–28. Additionally, mistrafficking of rhodopsin 
due to transgenic expression of a rhodopsin Pro23His mutant results in abnormal development of the OS and 
destabilization of OS discs29,30. While we cannot completely rule out that ARL2 disrupts trafficking of rhodopsin 
thereby affecting OS elaboration, it should be noted that the phenotype of the ARL2-Q70L transgenes is different 
from the rhodopsin knockout in two key aspects: the rhodopsin knockout does not produce mislocalization of the 
primary cilia or shortening of the inner segment27. Regardless of the mechanism leading to rhodopsin mislocali-
zation, it is likely that the slow degeneration of photoreceptors in ARL2-Q70L animals results from accumulation 
and overload of degradation pathways by rhodopsin28,31–33.
We demonstrate that expression of ARL2-Q70L leads to decreased stability of cilia and length of the ciliary 
axoneme both in the specialized primary cilium of the photoreceptor OS and the primary cilium of RPE1-hTERT. 
ARL2BP, a previously identified interacting partner of ARL2, was recently shown to be involved in the devel-
opment of cilia in photoreceptor cells in a mouse model34. As previously shown, mutations in ARL2BP results 
in retinitis pigmentosa and one specific mutation, c.134 T > G (p.Met45Arg), disrupts binding to ARL27. 
Furthermore, knockdown of either ARL2 or ARL2BP results in shortening of cilia in RPE cell lines7. Notably, the 
active ARL2-GTP (and not ARL2-GDP) selectively binds to ARL2BP. Therefore, it is expected that ARL2-Q70L 
Figure 8. ARL2-Q70L expression affects ciliary stability and ciliary length in RPE1-hTERT cell lines. (A) 
Immunofluorescence analysis of RPE1-hTERT cell sublines with HA-tagged ARL2-WT or ARL2-Q70L at 
48 hours of FBS(−) media incubation without (Dox(−)) or with (Dox(+)) doxycycline added at 24 hours of 
FBS(−) media incubation. Demonstrating immunoreactivity for DAPI (blue), HA (green), Acetyl α-tubulin 
(red), and γ-tubulin (magenta) (Scale Bar = 5 μm; Scale Bar (zoomed) = 3 μm). (B) Bar graphs illustrating the 
fraction ciliated (Ciliation) (Top) and average ciliary length (Bottom) normalized to Dox(−) control using at 
least 100 cells and 80 cilia per replicate. n = 3, *p < 0.05.
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would sequester ARL2BP preventing its proper function and resulting in stunted cilia in vivo. Although these data 
suggest a compelling role for ARL2BP in our model, our current studies do not support the interaction of ARL2 
with ARL2BP in photoreceptor cells34.
In addition, Newman et al. (2014) reported that ARL2 serves a role in mitochondrial morphology, motility, 
and maintenance of ATP levels that is independent of its role in tubulin regulation. However, only knockdown 
and expression of the dominant inactive mutant (ARL2-T30N) had effects on mitochondria while expression of 
the dominant active mutant (ARL2-Q70L) had no effects on mitochondrial endpoints and the greatest effect of 
all treatment groups on loss of microtubules15. Although we did not directly measure mitochondrial function 
and morphology, mitochondria appeared grossly normal and comparable to controls in ultrastructural analysis 
of ARL2-Q70L retina.
The photoreceptor cilium is a microtubule based-organelle containing the basal body, connecting cilium, 
and the axoneme, which extends into the OS. This organelle is the foundation of the photoreceptor OS and 
therefore necessary for the specialized function of capturing light. Formation of the cilium is complex and 
depends on the polymerization of tubulin to form microtubules. Interestingly, ARL2 is a known regulator of 
microtubules and tubulin in cell culture systems and expression of ARL2-Q70L in multiple cell lines results in 
destruction of microtubules and cell cycle arrest14,20. In addition, expression of wildtype ARL2 rescues microtu-
bules from tubulin binding cofactor D (TBCD)-mediated destruction20. A similar effect on microtubule stability 
was observed in the adenocarcinoma cell line, MCF7, where lines with the greatest expression of ARL2 showed 
higher content of polymerizable tubulin heterodimers and low expressing lines had reduced content35. ARL2 
was recently implicated in the regulation of soluble polymerizable tubulin pools, a role that relies on the for-
mation of a “TBC-DEG” chaperone complex composed of ARL2 and the tubulin chaperones TBCD and tubu-
lin binding cofactor E (TBCE)19. Furthermore, the ARL2-TBCD interaction has been found to be critical for 
maintenance of microtubule densities in cells and the TBCD-ARL2-β-tubulin trimer is fundamental to micro-
tubule dynamics36. Considering the major structural defects associated with ARL2-Q70L expression, including 
dysmorphic OS and IS, it is tempting to suggest that ARL2 plays a role in regulation of the polymerizable and 
or maintenance of the pool of tubulin in photoreceptors. Importantly, ARL2BP does not seem to play a role in 
tubulin regulation, at least outside of its minor effects on ciliary length14,15. Based on our findings and previous 
studies, future work will delve deeper into the role of ARL2 in coordination with “TBC-DEG” and the more 
fundamental TBCD-ARL2-β-tubulin trimer to answer the question of how this dysregulation leads to OS and IS 
dysmorphogenesis.
Finally, we demonstrate that ARL2-Q70L expression results in aberrant localization of the photoreceptor cil-
ium. Some of the cases of this phenotype can be explained by impending photoreceptor cell death that results 
in retraction of the OS and IS toward the cell body. However, there were many cases where the basal body and 
axoneme were localized at the base of the IS protruding from the cell in different directions. Because the trans-
gene is expressed after the point of apical localization of the basal body prior to axoneme elongation, it is likely 
that there is a defect in the process that positions this organelle at the apical surface, allowing the IS and OS to 
grow distally. We speculate that axonemal growth is required for proper OS development and that the cells con-
taining mislocalized cilia may express the transgene slightly earlier such that they are unable to produce even a 
rudimentary OS.
Current literature suggests that expression of ARL2-Q70L results in decrease of soluble tubulin pools, likely 
through interfering with tubulin folding. We posit that reduced pools of polymerizable tubulin or disruption of 
the TBCD-ARL2-β-tubulin trimer by constitutively active ARL2-Q70L leads to defects in ciliary development. 
Our results show dramatic effects on the architecture of photoreceptor cells, including the spatial organization 
of the cilia, basal body, and ciliary associated centriole. This disruption likely results in impaired development of 
the rod OS and progressive cell death. Future studies are necessary to fully elucidate the mechanisms underlying 
ARL2 regulation of tubulin, particularly at the connecting cilium of photoreceptor cells where the ARL2 protein 
is concentrated.
Methods
RNA isolation and qRT-PCR from retina. Mouse eyes were enucleated at indicated time points and dis-
sected under microscope (Zeiss Stemi DV4) to isolate the retina. RNA was isolated with TRI reagent (Sigma) 
according to manufacturer’s guidelines. Reverse-transcription PCR reactions containing 0.1–0.5 μg RNA were 
primed with Oligo-dT and random hexamers to generate cDNA. Expression of Arl2 and Arl3 was quantified by 
SYBR-green qPCR normalized to the expression of Glyceraldehyde-3-Phoshpate Dehydrogenase (Gapdh). qRT-
PCR primers for genes assessed were: Gapdh – Forward = AGACGGCCGCATCTTCTT and Reverse = TTCACA 
CCGACCTTCACCAT, Arl3 – Forward = TACTCCTGGGCTTGGACAAC and Reverse = TGTGACTGCACG 
CTTTTGAT, Arl2 – Forward = GAGCACCGCGGATTCAA and Reverse = GCAAAGATGAGGAGGGTTCG.
ARL2-Q70L transgenic mouse model generation. Transgenic model generation followed that of 
previously published work11. Briefly, a full-length human ARL2 clone (Thermo Scientific) was used to generate 
an ARL2 mutant construct with a tandem C-terminal hemagglutinin (HA) and FLAG tag that is driven by a 
4.4 kb rhodopsin promoter (Rhop). Of note, human ARL2 is 96% identical to the mouse protein and carries only 
one non-conservative amino acid substitution, R153 > C. This ARL2 construct was modified by site-directed 
mutagenesis to produce a glutamine (Q) to leucine (L) variant at position 70 (Q70L) using a mutant oligonu-
cleotide (5′-CCG CAG GGA CTT CAG GCC ACC CAC ATC-3′). After amplification, the PCR product was 
modified with a tandem C-terminal HA and FLAG tag and then cloned behind a 4.4 kb rhodopsin promoter. 
All clones selected were sequenced in both directions to confirm that there are no unintended mutations. After 
removal from the plasmid by digestion, Rhop-ARL2-Q70L-polyA was purified by agarose gel electrophoresis and 
elution. This purified DNA fragment was injected into pronuclei of oocytes from superovulated FVB/N females 
www.nature.com/scientificreports/
1 0SCiENtifiC REPoRts |         (2018) 8:16967  | DOI:10.1038/s41598-018-35395-3
(WVU Transgenic Core Facilities) and implanted in to pseudo-pregnant CD-1 females. Over 8 founder lines were 
examined and the lines utilized in this publication were selected because they exhibited the highest homogeneity 
of transgene expression in photoreceptor cells.
Genotyping and Founder Line Maintenance. ARL2-Q70L transgenic founders were initially identified 
by PCR of genomic DNA isolated from tail snips or ear punches using the following primers: 5′-GGA TCG TGA 
ATC AGC CTC TGG CTT-3′ and 5′-CTG CAT GCG CTG GCG GTC TGC-3′. PCR reactions utilized NEB 
quick load Taq polymerase with the following conditions: 1. 95 °C for 2 minutes, 2. 95 °C for 30 seconds, 3. 59 °C 
for 30 seconds, 4. 72 °C for 45 seconds, and 5. 72 °C for 5 minutes with steps 2–4 repeated for 33 cycles. Identified 
founders were crossed with 129/SV-E mice (Charles River) over multiple generations to eliminate the Pde6brd1 
mutation present in FVB mice (verified by PCR genotyping)37 as well as to ensure transgenic expression was 
resulting from a single locus. Animals were maintained under a 12-hour light/12-hour dark cycles with food 
and water ad libitium. All procedures were conducted in accordance with the NIH Guide for the Care and Use 
of Laboratory Animals. All proposed experiments were reviewed and approved by the Institutional Animal Care 
and Use Committee of West Virginia University.
Electroretinographic (ERG) analysis. Electroretinography (ERG) was performed as previously described 
using UTAS Visual Diagnostic System with BigShot Ganzfeld with UBA-4200 amplifier and interface, and 
EMWIN 9.0.0 software (LKC Technologies, Gaithersburg, MD, USA)11. After dark-adaptation overnight, a 
1:1 mixture of tropicamide:phenylephrine hydrochloride was used to dilate the test animal’s eyes. Mice were 
placed on a heated platform with continuous flow of 1.5% isofluorane with 2.5 liters per minute oxygen flow rate 
and a subcutaneous reference electrode. Corneal electrodes were placed making contact with the cornea using 
hypromellose solution (2% hypermellose in PBS) (Gonioscopic Prism Solution, Wilson Ophthalmic, Mustang, 
OK, USA). Scotopic responses were measured by exposure to flashes of white LED light starting at low inten-
sities and proceeding to higher intensities. Afterward, mice were light-adapted for 10 minutes under 30 cd/m2 
rod-saturating white background light for phototopic response measurements.
Generation of Antibody against full-length ARL2. ARL2 antibody was generated as previously 
described11. Briefly, ARL2 with a C-terminal his-tag was expressed in Origami E. coli strain (Novagen). Origami 
cells were grown to an OD600 ≈ 0.6 and protein production was induced with 1 mM IPTG for 18 hours at 18 °C. 
The protein was purified from the soluble fraction using a Nickel His Affinity Column and the eluate was supplied 
to Pacific Immunology Corp. for generation of the antibody in rabbits. Antibody serum was then purified against 
a GST-ARL2 fusion protein and tested via western blot and immunofluorescence microscopy in both HEK 293 
cells expressing ARL2 and retinal extracts.
Immunoblots. Flash frozen dissected retinal samples from enucleated eyes were sonicated in phosphate buff-
ered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4·7H2O, 1.4 mM KH2PO4, with protease inhibitor 
cocktail (Roche)). After measurement of protein concentration using spectrophotometry (NanoDrop - Thermo 
Fisher Scientific, Inc), a sample volume equal to 150 µg total protein was loaded per well of a 12% or 15% poly-
acrylamide SDS-PAGE resolving gel (Criterion Midi format, Bio-Rad). Proteins were then resolved and transferred 
onto polyvinylidene difluoride membranes (Immunobilon-FL, Millipore, Billerica). Membranes were blocked 
for 30 minutes at room temperature (Western Blot Blocking Buffer – Rockland Inc.) and incubated with primary 
antibodies at a dilution of 1:2000 overnight at 4 °C. After washing in PBST (PBS with 0.1% Tween-20) 3 times for 
5 minutes, secondary antibodies (goat anti-rabbit Alexa 680 (or 800), goat anti-rat Alexa 800, or goat anti-mouse 
Alexa 680 (Invitrogen)) were applied for 30 minutes at room temperature. After washing again in PBST, blots were 
imaged using the Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, NE, USA).
Antibodies. The following antibodies were used for immunoblot and immunofluorescence analysis at a dilu-
tion of 1:2000 or 1:1000, respectively, unless otherwise noted: rabbit anti-PDE6α (Pierce), rabbit anti-PDE6β 
(Pierce), rabbit anti-PDE6γ (Pierce), assembled PDE6 (ROS1) (generously provided by Drs. Ted Wensel (Baylor 
College) and Rick Cote (University of New Hampshire), rabbit anti-Transducin-αt1 (Santa Cruz), mouse 
anti-cytochrome c oxidase subunit I (COX I) (MS404 MitoSciences), rabbit anti-Transducin-γt1 (Santa Cruz), 
mouse anti-GRK1 (Thermo Fisher), mouse anti-CNGA1 (UC Davis/NIH NeuroMab Facility), rabbit anti-RDS-c 
(Peripherin-2) (Gabriel Travis, University of California, Los Angeles, CA), mouse anti-1D4 (rhodopsin) (gift 
from Dr. Ted Wensel, Baylor Collect of Medicine), rat anti-HA antibody (Roche), chicken anti-RP1 (gift from 
Dr. Qin Liu Mass. Eye and Ear, Boston, MA), and rabbit anti-ARL2 (1:1000) (see above). DAPI (1:1000) (4′,6-dia
mindino-2-phenylindole, Invitrogen) and propidium iodide (PI) (1:2000) (EMD Millipore, Billerica, MA, USA) 
were also used in indirect immunofluorescence.
Immunofluorescence Analysis. Indirect immunofluorescence was utilized to analyze protein localization 
in retinal cross-sections. For general immunofluorescence studies, enucleated eyes were immersed in 4% PFA in 
PBS for 15 minutes, after which the anterior segments were removed and the eyecups were placed back in fixative 
for a total of 3 hours. Fixed eyecups were washed with PBS and kept in 20% sucrose in PBS overnight at 4 °C. 
After incubation in a 1:1 mixture of 20% sucrose solution:OCT (Cryo Optimal Cutting Temperature Compound, 
Sakura) for 2 hours, eyecups were flash frozen in OCT. Alternatively, for staining of ciliary markers, anterior 
segments were dissected immediately after enucleation and eyes were placed in 4% PFA for 30 seconds. These 
eyecups were flash frozen in OCT. Serial retinal cross-sections at 16 µm thickness (or 10 μm for ciliary markers) 
were mounted on Superfrost Plus slides (Fisher Scientific). Sections were blocked for 1 hour (PBS with 5% goat 
serum, 0.5% Triton X-100, 0.05% sodium azide) and incubated with primary antibody overnight at 4 °C then 
washed with PBS + 0.1% Triton X-100 three times for 5 minutes. Secondary antibodies (DAPI nuclear stain 405, 
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anti-Rat 568, anti-Rabbit 488 (or 568), anti-mouse 488 (or 568)) were incubated for 1 hour at room temperature 
at a dilution of 1:1000. Sections were washed again and cover slipped with ProLong Gold (Life Technologies). 
Confocal imaging was performed using the Nikon C2 Confocal Microscope System. Images were processed using 
ImageJ image processing software.
RPE1-hTERT Stable Cell Line Generation and Analysis. RPE1-hTERT cells were cultured according 
to suppliers recommendations from ATCC (https://www.atcc.org). For stable cell subline generation ARL2-HA, 
ARL2-Q70L-HA, Arl3-HA and Arl3-Q70L-HA were subcloned into pLUT backbone under doxycycline induci-
ble promoter. Viral particles were generated as previously described23. Infections were followed by selection with 
8 µg/ml of puromycin until stably growing clones were established. To induce ciliation, stable cells lines from 
above were incubated in the absence of FBS (FBS(−) for 48 hours. After 24 hours of FBS(−) incubation, doxycy-
cline was added to induce expression of ARL2-HA, ARL2-Q70L-HA, Arl3-HA or Arl3-Q70L-HA. Measurements 
of ciliation (fraction of cells expressing the exogenous protein that have cilia) and cilia length were completed 
48 hours after FBS(−) incubation using immunofluorescence analysis with acetyl-α-tubulin (axonemal marker) 
co-labeled with γ-tubulin (basal body marker). Measurements were compared between dox(−) controls and 
dox(+) samples.
Toluidine Blue Histological Analysis. Eyes were enucleated with the 12 o’clock position marked for refer-
ence with a red lipophilic dye and immediately fixed in Excalibur Pathology Fixation Buffer at room temperature. 
Fixed eyes were embedded in paraffin, sectioned at 2 μm, and stained with toluidine blue by Excalibur Pathology 
(Norman, OK). Images were captured with a Nikon light microscope. Analysis, including measurement of OS, IS, 
and ONL length was performed using ImageJ.
Ultrastructural Analysis. Enucleated eyes fixed in 2% paraformaldehyde, 2.5% glutaraldehyde, 0.1 M caco-
dylate buffer, pH 7.5 for 30 minutes at room temperature were dissected removing the anterior segment and lens 
then fixed further for at least 2 days. Fixed eyecup was dissected into 6–8 wedge-shaped pieces. Wedges were 
dehydrated in a graded ethanol series, osmicated, en bloc stained with uranyl acetate, and then embedded in 
Polybed 812 (PolySciences, Inc., Warrington, PA, USA). Semi-thin (1 μm) sections were collected onto glass 
slides, stained with toluidine blue, and visualized using a Zeiss Axioimager 2 microscope equipped with EC 
Plan-Neofluar 40 × (N.A. 0.75) and 100 × (1.3 N.A.) objectives. Thin sections (ca. 80 nm) from selected wedges 
were collected onto copper grids, stained with 2% uranyl acetate and lead citrate, and imaged using an FEI 
Morgagni transmission electron microscope at 80 kV.
Experimental design and Statistical Analysis. All quantitative analysis was performed on age-matched 
littermate wild-type controls and ARL2-Q70L transgenic mice with a minimum sample size of 3 animals per 
group compared. For immunohistochemical analysis, at least 4 sections were imaged per sample and data 
were derived from at minimum n > 3 independent experiments. Data are presented as mean ± standard error. 
Unpaired Student’s t tests were conducted to compare measured values between control and mutant samples. 
For cilia measurements, 80–100 cilia were measured for each animal or culture (n = 3). Image and densitometry 
analysis were performed using ImageJ-FIJI 1.50i along with the Bio-Formats plugin (NIH).
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author upon request.
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